-+ 0.00%
-+ 0.00%
-+ 0.00%

LIGAND PHARMACEUTICALS, INC. : OPPENHEIMER RAISES TARGET PRICE TO $346 FROM $334

Reuters·10/30/2026 12:05:18

Please log in to view news